This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alper Toker Yusuf Bayrak Serhan Tanju Sedat Ziyade Osman Eroglu Sukru Dilege Goksel Kalayci Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Toker, A. Articles by Kalayci, G. Search for Related Content PubMed PubMed Citation Articles by Toker, A. Articles by Kalayci, G. Related Collections Lung - cancer

Invasive staging of superior mediastinum in non-small cell lung cancer patients with specific indications

^a Department of Thoracic Surgery, Istanbul Medical School, Istanbul University, Istanbul, Turkey
^b Department of Pathology, Istanbul Medical School, Istanbul University, Istanbul, Turkey

^* Corresponding author. Inönü Cad. Yldz Sok., STFA Bloklar, B/6 blok No. 13, 81090 Kozyata, Istanbul, Turkey. Tel.: +90-532-422-38-02; fax: +90-216-338-43-80
aetoker{at}superonline.com

This prospective study was done between February 2001 and December 2002 on 84 non-small cell lung cancer patients who were apparently operable. We selectively performed mediastinoscopy to 46 patients (54.76%, group 1) with the following indications: clinical T4 tumor, high operative risk, radiologically enlarged mediastinal lymph nodes, clinical T3 tumors with central location, radiologically identified mediastinal lymph nodes of any size with adeno or large cell carcinoma histology. Other 38 patients (45.23%, group 2) underwent thoracotomy without mediastinoscopy. Sensitivity, specificity, negative predictive value and positive predictive value of the indications were calculated. Cost analysis was done in the 84 patients and the results were compared with alternative mediastinal staging strategies (vs. routine, and vs. selectively to patients with radiologically positive mediastinal lymph nodes) if they had been applied to our population. Group 1 had higher selectivity to differentiate N2 patients (). Sensitivity, specificity, negative predictive value and positive predictive value of indications were calculated as: 0.85, 0.54, 0.92 and 0.36, respectively. Our approach was most economical in terms of total cost per patient and money spent unnecessarily per patient. Mediastinal evaluation in operable lung cancer patients should decrease the number of surgical procedures, N2 disease found at thoracotomy and cost.

Key Words: Lung cancer; Mediastinoscopy; Indications